nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivaroxaban—CYP2J2—Cholecalciferol—ulcerative colitis	0.361	0.61	CbGbCtD
Rivaroxaban—ABCB1—ulcerative colitis	0.274	1	CbGaD
Rivaroxaban—CYP3A4—Budesonide—ulcerative colitis	0.0262	0.0443	CbGbCtD
Rivaroxaban—CYP3A5—Sulfasalazine—ulcerative colitis	0.0227	0.0385	CbGbCtD
Rivaroxaban—ABCB1—Methylprednisolone—ulcerative colitis	0.0195	0.033	CbGbCtD
Rivaroxaban—CYP3A5—Hydrocortisone—ulcerative colitis	0.0182	0.0309	CbGbCtD
Rivaroxaban—ABCB1—Betamethasone—ulcerative colitis	0.0127	0.0215	CbGbCtD
Rivaroxaban—ABCB1—Prednisolone—ulcerative colitis	0.0125	0.0212	CbGbCtD
Rivaroxaban—ABCB1—Hydrocortisone—ulcerative colitis	0.0119	0.0201	CbGbCtD
Rivaroxaban—ABCB1—Prednisone—ulcerative colitis	0.0118	0.02	CbGbCtD
Rivaroxaban—CYP3A4—Methylprednisolone—ulcerative colitis	0.0117	0.0198	CbGbCtD
Rivaroxaban—CYP3A4—Nicotine—ulcerative colitis	0.0114	0.0193	CbGbCtD
Rivaroxaban—CYP3A5—Dexamethasone—ulcerative colitis	0.0113	0.0192	CbGbCtD
Rivaroxaban—CYP3A4—Cholecalciferol—ulcerative colitis	0.0102	0.0173	CbGbCtD
Rivaroxaban—CYP3A4—Triamcinolone—ulcerative colitis	0.00886	0.015	CbGbCtD
Rivaroxaban—CYP3A4—Betamethasone—ulcerative colitis	0.0076	0.0129	CbGbCtD
Rivaroxaban—CYP3A4—Prednisolone—ulcerative colitis	0.0075	0.0127	CbGbCtD
Rivaroxaban—ABCB1—Dexamethasone—ulcerative colitis	0.00738	0.0125	CbGbCtD
Rivaroxaban—CYP3A4—Hydrocortisone—ulcerative colitis	0.00711	0.012	CbGbCtD
Rivaroxaban—CYP3A4—Prednisone—ulcerative colitis	0.00709	0.012	CbGbCtD
Rivaroxaban—CYP3A4—Dexamethasone—ulcerative colitis	0.00442	0.00749	CbGbCtD
Rivaroxaban—F10—Common Pathway—PROCR—ulcerative colitis	0.00433	0.236	CbGpPWpGaD
Rivaroxaban—F10—Formation of Fibrin Clot (Clotting Cascade)—PROCR—ulcerative colitis	0.00249	0.136	CbGpPWpGaD
Rivaroxaban—F10—Complement and Coagulation Cascades—MASP2—ulcerative colitis	0.00121	0.0661	CbGpPWpGaD
Rivaroxaban—F10—Beta2 integrin cell surface interactions—ITGAL—ulcerative colitis	0.00113	0.0618	CbGpPWpGaD
Rivaroxaban—F10—Beta2 integrin cell surface interactions—FCGR2A—ulcerative colitis	0.000981	0.0536	CbGpPWpGaD
Rivaroxaban—F10—Beta2 integrin cell surface interactions—VCAM1—ulcerative colitis	0.000688	0.0376	CbGpPWpGaD
Rivaroxaban—CYP2J2—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000568	0.031	CbGpPWpGaD
Rivaroxaban—F10—Beta2 integrin cell surface interactions—ICAM1—ulcerative colitis	0.000468	0.0256	CbGpPWpGaD
Rivaroxaban—F10—Post-translational protein modification—MUC3A—ulcerative colitis	0.000455	0.0248	CbGpPWpGaD
Rivaroxaban—CYP2J2—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000398	0.0217	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—MICA—ulcerative colitis	0.000318	0.0174	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—PROCR—ulcerative colitis	0.0003	0.0164	CbGpPWpGaD
Rivaroxaban—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.000231	0.0126	CbGpPWpGaD
Rivaroxaban—F10—Post-translational protein modification—MUC2—ulcerative colitis	0.000222	0.0121	CbGpPWpGaD
Rivaroxaban—CYP2J2—Arachidonic acid metabolism—PTGS2—ulcerative colitis	0.000218	0.0119	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—MUC3A—ulcerative colitis	0.000216	0.0118	CbGpPWpGaD
Rivaroxaban—CYP2J2—Biological oxidations—PTGS1—ulcerative colitis	0.000211	0.0115	CbGpPWpGaD
Rivaroxaban—ABCB1—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000204	0.0112	CbGpPWpGaD
Rivaroxaban—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000164	0.00894	CbGpPWpGaD
Rivaroxaban—Haemoglobin—Betamethasone—ulcerative colitis	0.000158	0.00135	CcSEcCtD
Rivaroxaban—Haemoglobin—Dexamethasone—ulcerative colitis	0.000158	0.00135	CcSEcCtD
Rivaroxaban—Pain—Mesalazine—ulcerative colitis	0.000157	0.00134	CcSEcCtD
Rivaroxaban—Constipation—Mesalazine—ulcerative colitis	0.000157	0.00134	CcSEcCtD
Rivaroxaban—Haemorrhage—Betamethasone—ulcerative colitis	0.000157	0.00134	CcSEcCtD
Rivaroxaban—Haemorrhage—Dexamethasone—ulcerative colitis	0.000157	0.00134	CcSEcCtD
Rivaroxaban—Angiopathy—Methylprednisolone—ulcerative colitis	0.000157	0.00134	CcSEcCtD
Rivaroxaban—Immune system disorder—Methylprednisolone—ulcerative colitis	0.000156	0.00133	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.000156	0.00133	CcSEcCtD
Rivaroxaban—Diarrhoea—Budesonide—ulcerative colitis	0.000155	0.00132	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Prednisolone—ulcerative colitis	0.000152	0.0013	CcSEcCtD
Rivaroxaban—Feeling abnormal—Mesalazine—ulcerative colitis	0.000151	0.00129	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.00015	0.00128	CcSEcCtD
Rivaroxaban—Angioedema—Prednisolone—ulcerative colitis	0.00015	0.00128	CcSEcCtD
Rivaroxaban—Dizziness—Budesonide—ulcerative colitis	0.000149	0.00128	CcSEcCtD
Rivaroxaban—Hypersensitivity—Azathioprine—ulcerative colitis	0.000149	0.00127	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Hydrocortisone—ulcerative colitis	0.000149	0.00127	CcSEcCtD
Rivaroxaban—Malaise—Prednisolone—ulcerative colitis	0.000148	0.00126	CcSEcCtD
Rivaroxaban—Syncope—Prednisolone—ulcerative colitis	0.000147	0.00126	CcSEcCtD
Rivaroxaban—Eye disorder—Dexamethasone—ulcerative colitis	0.000147	0.00125	CcSEcCtD
Rivaroxaban—Eye disorder—Betamethasone—ulcerative colitis	0.000147	0.00125	CcSEcCtD
Rivaroxaban—Angioedema—Hydrocortisone—ulcerative colitis	0.000146	0.00125	CcSEcCtD
Rivaroxaban—Urticaria—Mesalazine—ulcerative colitis	0.000146	0.00125	CcSEcCtD
Rivaroxaban—Back pain—Triamcinolone—ulcerative colitis	0.000146	0.00125	CcSEcCtD
Rivaroxaban—Abdominal pain—Mesalazine—ulcerative colitis	0.000145	0.00124	CcSEcCtD
Rivaroxaban—Malaise—Hydrocortisone—ulcerative colitis	0.000144	0.00123	CcSEcCtD
Rivaroxaban—Loss of consciousness—Prednisolone—ulcerative colitis	0.000144	0.00123	CcSEcCtD
Rivaroxaban—Vomiting—Budesonide—ulcerative colitis	0.000144	0.00123	CcSEcCtD
Rivaroxaban—Syncope—Hydrocortisone—ulcerative colitis	0.000144	0.00123	CcSEcCtD
Rivaroxaban—Angiopathy—Dexamethasone—ulcerative colitis	0.000143	0.00122	CcSEcCtD
Rivaroxaban—Angiopathy—Betamethasone—ulcerative colitis	0.000143	0.00122	CcSEcCtD
Rivaroxaban—Rash—Budesonide—ulcerative colitis	0.000143	0.00122	CcSEcCtD
Rivaroxaban—Dermatitis—Budesonide—ulcerative colitis	0.000142	0.00122	CcSEcCtD
Rivaroxaban—Headache—Budesonide—ulcerative colitis	0.000142	0.00121	CcSEcCtD
Rivaroxaban—Loss of consciousness—Hydrocortisone—ulcerative colitis	0.000141	0.0012	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Triamcinolone—ulcerative colitis	0.00014	0.00119	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Methylprednisolone—ulcerative colitis	0.00014	0.00119	CcSEcCtD
Rivaroxaban—Diarrhoea—Azathioprine—ulcerative colitis	0.000138	0.00118	CcSEcCtD
Rivaroxaban—Discomfort—Prednisolone—ulcerative colitis	0.000138	0.00118	CcSEcCtD
Rivaroxaban—Angioedema—Triamcinolone—ulcerative colitis	0.000138	0.00118	CcSEcCtD
Rivaroxaban—Haemoglobin—Prednisone—ulcerative colitis	0.000138	0.00118	CcSEcCtD
Rivaroxaban—Angioedema—Methylprednisolone—ulcerative colitis	0.000137	0.00117	CcSEcCtD
Rivaroxaban—Haemorrhage—Prednisone—ulcerative colitis	0.000137	0.00117	CcSEcCtD
Rivaroxaban—Malaise—Triamcinolone—ulcerative colitis	0.000136	0.00116	CcSEcCtD
Rivaroxaban—Malaise—Methylprednisolone—ulcerative colitis	0.000136	0.00116	CcSEcCtD
Rivaroxaban—Hypersensitivity—Mesalazine—ulcerative colitis	0.000135	0.00116	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000135	0.00116	CcSEcCtD
Rivaroxaban—Syncope—Triamcinolone—ulcerative colitis	0.000135	0.00115	CcSEcCtD
Rivaroxaban—Syncope—Methylprednisolone—ulcerative colitis	0.000135	0.00115	CcSEcCtD
Rivaroxaban—Discomfort—Hydrocortisone—ulcerative colitis	0.000135	0.00115	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Prednisone—ulcerative colitis	0.000135	0.00115	CcSEcCtD
Rivaroxaban—Nausea—Budesonide—ulcerative colitis	0.000134	0.00115	CcSEcCtD
Rivaroxaban—Oedema—Prednisolone—ulcerative colitis	0.000134	0.00114	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Prednisolone—ulcerative colitis	0.000134	0.00114	CcSEcCtD
Rivaroxaban—Dizziness—Azathioprine—ulcerative colitis	0.000133	0.00114	CcSEcCtD
Rivaroxaban—Loss of consciousness—Triamcinolone—ulcerative colitis	0.000133	0.00113	CcSEcCtD
Rivaroxaban—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.000132	0.00113	CcSEcCtD
Rivaroxaban—Asthenia—Mesalazine—ulcerative colitis	0.000132	0.00113	CcSEcCtD
Rivaroxaban—Shock—Prednisolone—ulcerative colitis	0.000132	0.00112	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.000131	0.00112	CcSEcCtD
Rivaroxaban—Oedema—Hydrocortisone—ulcerative colitis	0.000131	0.00112	CcSEcCtD
Rivaroxaban—Tachycardia—Prednisolone—ulcerative colitis	0.000131	0.00112	CcSEcCtD
Rivaroxaban—Pruritus—Mesalazine—ulcerative colitis	0.00013	0.00111	CcSEcCtD
Rivaroxaban—Infection—Hydrocortisone—ulcerative colitis	0.00013	0.00111	CcSEcCtD
Rivaroxaban—Shock—Hydrocortisone—ulcerative colitis	0.000129	0.0011	CcSEcCtD
Rivaroxaban—Vomiting—Azathioprine—ulcerative colitis	0.000128	0.0011	CcSEcCtD
Rivaroxaban—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000128	0.00109	CcSEcCtD
Rivaroxaban—Eye disorder—Prednisone—ulcerative colitis	0.000128	0.00109	CcSEcCtD
Rivaroxaban—Tachycardia—Hydrocortisone—ulcerative colitis	0.000128	0.00109	CcSEcCtD
Rivaroxaban—Rash—Azathioprine—ulcerative colitis	0.000127	0.00109	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000127	0.00109	CcSEcCtD
Rivaroxaban—Dermatitis—Azathioprine—ulcerative colitis	0.000127	0.00109	CcSEcCtD
Rivaroxaban—Skin disorder—Hydrocortisone—ulcerative colitis	0.000127	0.00108	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Betamethasone—ulcerative colitis	0.000127	0.00108	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.000127	0.00108	CcSEcCtD
Rivaroxaban—Discomfort—Triamcinolone—ulcerative colitis	0.000127	0.00108	CcSEcCtD
Rivaroxaban—Discomfort—Methylprednisolone—ulcerative colitis	0.000127	0.00108	CcSEcCtD
Rivaroxaban—Headache—Azathioprine—ulcerative colitis	0.000126	0.00108	CcSEcCtD
Rivaroxaban—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	0.000126	0.00689	CbGpPWpGaD
Rivaroxaban—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000126	0.00688	CbGpPWpGaD
Rivaroxaban—Diarrhoea—Mesalazine—ulcerative colitis	0.000126	0.00107	CcSEcCtD
Rivaroxaban—Dry mouth—Triamcinolone—ulcerative colitis	0.000126	0.00107	CcSEcCtD
Rivaroxaban—Angioedema—Betamethasone—ulcerative colitis	0.000125	0.00107	CcSEcCtD
Rivaroxaban—Angioedema—Dexamethasone—ulcerative colitis	0.000125	0.00107	CcSEcCtD
Rivaroxaban—Angiopathy—Prednisone—ulcerative colitis	0.000124	0.00106	CcSEcCtD
Rivaroxaban—Immune system disorder—Prednisone—ulcerative colitis	0.000124	0.00106	CcSEcCtD
Rivaroxaban—Malaise—Dexamethasone—ulcerative colitis	0.000123	0.00105	CcSEcCtD
Rivaroxaban—Malaise—Betamethasone—ulcerative colitis	0.000123	0.00105	CcSEcCtD
Rivaroxaban—Oedema—Triamcinolone—ulcerative colitis	0.000123	0.00105	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000123	0.00105	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.000123	0.00105	CcSEcCtD
Rivaroxaban—Syncope—Betamethasone—ulcerative colitis	0.000123	0.00105	CcSEcCtD
Rivaroxaban—Syncope—Dexamethasone—ulcerative colitis	0.000123	0.00105	CcSEcCtD
Rivaroxaban—Infection—Triamcinolone—ulcerative colitis	0.000122	0.00104	CcSEcCtD
Rivaroxaban—Hypotension—Hydrocortisone—ulcerative colitis	0.000122	0.00104	CcSEcCtD
Rivaroxaban—Infection—Methylprednisolone—ulcerative colitis	0.000122	0.00104	CcSEcCtD
Rivaroxaban—Dizziness—Mesalazine—ulcerative colitis	0.000122	0.00104	CcSEcCtD
Rivaroxaban—Shock—Triamcinolone—ulcerative colitis	0.000121	0.00103	CcSEcCtD
Rivaroxaban—Shock—Methylprednisolone—ulcerative colitis	0.000121	0.00103	CcSEcCtD
Rivaroxaban—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.00012	0.00103	CcSEcCtD
Rivaroxaban—Loss of consciousness—Dexamethasone—ulcerative colitis	0.00012	0.00103	CcSEcCtD
Rivaroxaban—Loss of consciousness—Betamethasone—ulcerative colitis	0.00012	0.00103	CcSEcCtD
Rivaroxaban—Tachycardia—Triamcinolone—ulcerative colitis	0.00012	0.00103	CcSEcCtD
Rivaroxaban—Nausea—Azathioprine—ulcerative colitis	0.00012	0.00102	CcSEcCtD
Rivaroxaban—Tachycardia—Methylprednisolone—ulcerative colitis	0.00012	0.00102	CcSEcCtD
Rivaroxaban—Skin disorder—Methylprednisolone—ulcerative colitis	0.000119	0.00102	CcSEcCtD
Rivaroxaban—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000117	0.00641	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—GNA12—ulcerative colitis	0.000117	0.0064	CbGpPWpGaD
Rivaroxaban—Vomiting—Mesalazine—ulcerative colitis	0.000117	0.000998	CcSEcCtD
Rivaroxaban—Rash—Mesalazine—ulcerative colitis	0.000116	0.00099	CcSEcCtD
Rivaroxaban—Dermatitis—Mesalazine—ulcerative colitis	0.000116	0.000989	CcSEcCtD
Rivaroxaban—Headache—Mesalazine—ulcerative colitis	0.000115	0.000983	CcSEcCtD
Rivaroxaban—Discomfort—Betamethasone—ulcerative colitis	0.000115	0.000983	CcSEcCtD
Rivaroxaban—Discomfort—Dexamethasone—ulcerative colitis	0.000115	0.000983	CcSEcCtD
Rivaroxaban—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000115	0.000983	CcSEcCtD
Rivaroxaban—F10—Hemostasis—ITGAL—ulcerative colitis	0.000115	0.00628	CbGpPWpGaD
Rivaroxaban—Hypotension—Methylprednisolone—ulcerative colitis	0.000115	0.00098	CcSEcCtD
Rivaroxaban—CYP3A5—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000115	0.00626	CbGpPWpGaD
Rivaroxaban—Pain—Prednisolone—ulcerative colitis	0.000114	0.000977	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000113	0.000964	CcSEcCtD
Rivaroxaban—Fatigue—Hydrocortisone—ulcerative colitis	0.000113	0.000962	CcSEcCtD
Rivaroxaban—Pain—Hydrocortisone—ulcerative colitis	0.000112	0.000955	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Betamethasone—ulcerative colitis	0.000112	0.000954	CcSEcCtD
Rivaroxaban—Oedema—Betamethasone—ulcerative colitis	0.000112	0.000954	CcSEcCtD
Rivaroxaban—Oedema—Dexamethasone—ulcerative colitis	0.000112	0.000954	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.000112	0.000954	CcSEcCtD
Rivaroxaban—Infection—Dexamethasone—ulcerative colitis	0.000111	0.000948	CcSEcCtD
Rivaroxaban—Infection—Betamethasone—ulcerative colitis	0.000111	0.000948	CcSEcCtD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—HNF4A—ulcerative colitis	0.000111	0.00606	CbGpPWpGaD
Rivaroxaban—Ill-defined disorder—Prednisone—ulcerative colitis	0.000111	0.000944	CcSEcCtD
Rivaroxaban—Feeling abnormal—Prednisolone—ulcerative colitis	0.00011	0.000942	CcSEcCtD
Rivaroxaban—Anaemia—Prednisone—ulcerative colitis	0.00011	0.000941	CcSEcCtD
Rivaroxaban—Shock—Dexamethasone—ulcerative colitis	0.00011	0.000938	CcSEcCtD
Rivaroxaban—Shock—Betamethasone—ulcerative colitis	0.00011	0.000938	CcSEcCtD
Rivaroxaban—Dyspnoea—Triamcinolone—ulcerative colitis	0.00011	0.000937	CcSEcCtD
Rivaroxaban—Nervous system disorder—Dexamethasone—ulcerative colitis	0.00011	0.000935	CcSEcCtD
Rivaroxaban—Nervous system disorder—Betamethasone—ulcerative colitis	0.00011	0.000935	CcSEcCtD
Rivaroxaban—Nausea—Mesalazine—ulcerative colitis	0.000109	0.000932	CcSEcCtD
Rivaroxaban—Tachycardia—Betamethasone—ulcerative colitis	0.000109	0.000931	CcSEcCtD
Rivaroxaban—Tachycardia—Dexamethasone—ulcerative colitis	0.000109	0.000931	CcSEcCtD
Rivaroxaban—Angioedema—Prednisone—ulcerative colitis	0.000109	0.00093	CcSEcCtD
Rivaroxaban—Dyspepsia—Triamcinolone—ulcerative colitis	0.000108	0.000925	CcSEcCtD
Rivaroxaban—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000108	0.000923	CcSEcCtD
Rivaroxaban—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.000108	0.00092	CcSEcCtD
Rivaroxaban—Malaise—Prednisone—ulcerative colitis	0.000107	0.000918	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000107	0.000913	CcSEcCtD
Rivaroxaban—Syncope—Prednisone—ulcerative colitis	0.000107	0.000913	CcSEcCtD
Rivaroxaban—Urticaria—Prednisolone—ulcerative colitis	0.000106	0.000908	CcSEcCtD
Rivaroxaban—Fatigue—Triamcinolone—ulcerative colitis	0.000106	0.000906	CcSEcCtD
Rivaroxaban—Fatigue—Methylprednisolone—ulcerative colitis	0.000106	0.000904	CcSEcCtD
Rivaroxaban—F10—Metabolism of proteins—MUC2—ulcerative colitis	0.000105	0.00576	CbGpPWpGaD
Rivaroxaban—Pain—Triamcinolone—ulcerative colitis	0.000105	0.000899	CcSEcCtD
Rivaroxaban—Loss of consciousness—Prednisone—ulcerative colitis	0.000105	0.000894	CcSEcCtD
Rivaroxaban—Hypotension—Betamethasone—ulcerative colitis	0.000104	0.000891	CcSEcCtD
Rivaroxaban—Hypotension—Dexamethasone—ulcerative colitis	0.000104	0.000891	CcSEcCtD
Rivaroxaban—Urticaria—Hydrocortisone—ulcerative colitis	0.000104	0.000887	CcSEcCtD
Rivaroxaban—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000103	0.000882	CcSEcCtD
Rivaroxaban—Feeling abnormal—Triamcinolone—ulcerative colitis	0.000101	0.000866	CcSEcCtD
Rivaroxaban—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.000101	0.000864	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000101	0.00086	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.0001	0.000858	CcSEcCtD
Rivaroxaban—Discomfort—Prednisone—ulcerative colitis	0.0001	0.000856	CcSEcCtD
Rivaroxaban—Hypersensitivity—Prednisolone—ulcerative colitis	9.86e-05	0.000842	CcSEcCtD
Rivaroxaban—Dyspepsia—Dexamethasone—ulcerative colitis	9.83e-05	0.00084	CcSEcCtD
Rivaroxaban—Dyspepsia—Betamethasone—ulcerative colitis	9.83e-05	0.00084	CcSEcCtD
Rivaroxaban—Urticaria—Triamcinolone—ulcerative colitis	9.78e-05	0.000835	CcSEcCtD
Rivaroxaban—Urticaria—Methylprednisolone—ulcerative colitis	9.76e-05	0.000833	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Prednisone—ulcerative colitis	9.73e-05	0.000831	CcSEcCtD
Rivaroxaban—Oedema—Prednisone—ulcerative colitis	9.73e-05	0.000831	CcSEcCtD
Rivaroxaban—Abdominal pain—Methylprednisolone—ulcerative colitis	9.71e-05	0.000829	CcSEcCtD
Rivaroxaban—Infection—Prednisone—ulcerative colitis	9.66e-05	0.000825	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	9.64e-05	0.000823	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Betamethasone—ulcerative colitis	9.64e-05	0.000823	CcSEcCtD
Rivaroxaban—Hypersensitivity—Hydrocortisone—ulcerative colitis	9.63e-05	0.000822	CcSEcCtD
Rivaroxaban—Fatigue—Betamethasone—ulcerative colitis	9.63e-05	0.000822	CcSEcCtD
Rivaroxaban—Fatigue—Dexamethasone—ulcerative colitis	9.63e-05	0.000822	CcSEcCtD
Rivaroxaban—Shock—Prednisone—ulcerative colitis	9.57e-05	0.000817	CcSEcCtD
Rivaroxaban—Pain—Dexamethasone—ulcerative colitis	9.55e-05	0.000816	CcSEcCtD
Rivaroxaban—Pain—Betamethasone—ulcerative colitis	9.55e-05	0.000816	CcSEcCtD
Rivaroxaban—Nervous system disorder—Prednisone—ulcerative colitis	9.54e-05	0.000815	CcSEcCtD
Rivaroxaban—Tachycardia—Prednisone—ulcerative colitis	9.49e-05	0.000811	CcSEcCtD
Rivaroxaban—Skin disorder—Prednisone—ulcerative colitis	9.45e-05	0.000807	CcSEcCtD
Rivaroxaban—Asthenia—Hydrocortisone—ulcerative colitis	9.38e-05	0.000801	CcSEcCtD
Rivaroxaban—Pruritus—Hydrocortisone—ulcerative colitis	9.25e-05	0.00079	CcSEcCtD
Rivaroxaban—Feeling abnormal—Betamethasone—ulcerative colitis	9.2e-05	0.000786	CcSEcCtD
Rivaroxaban—Feeling abnormal—Dexamethasone—ulcerative colitis	9.2e-05	0.000786	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Dexamethasone—ulcerative colitis	9.13e-05	0.00078	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Betamethasone—ulcerative colitis	9.13e-05	0.00078	CcSEcCtD
Rivaroxaban—Hypersensitivity—Triamcinolone—ulcerative colitis	9.07e-05	0.000774	CcSEcCtD
Rivaroxaban—Hypersensitivity—Methylprednisolone—ulcerative colitis	9.05e-05	0.000773	CcSEcCtD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	9.02e-05	0.00493	CbGpPWpGaD
Rivaroxaban—Diarrhoea—Hydrocortisone—ulcerative colitis	8.94e-05	0.000764	CcSEcCtD
Rivaroxaban—Urticaria—Dexamethasone—ulcerative colitis	8.87e-05	0.000758	CcSEcCtD
Rivaroxaban—Urticaria—Betamethasone—ulcerative colitis	8.87e-05	0.000758	CcSEcCtD
Rivaroxaban—Dizziness—Prednisolone—ulcerative colitis	8.85e-05	0.000756	CcSEcCtD
Rivaroxaban—Asthenia—Triamcinolone—ulcerative colitis	8.83e-05	0.000754	CcSEcCtD
Rivaroxaban—Abdominal pain—Dexamethasone—ulcerative colitis	8.83e-05	0.000754	CcSEcCtD
Rivaroxaban—Abdominal pain—Betamethasone—ulcerative colitis	8.83e-05	0.000754	CcSEcCtD
Rivaroxaban—Asthenia—Methylprednisolone—ulcerative colitis	8.81e-05	0.000752	CcSEcCtD
Rivaroxaban—Pruritus—Triamcinolone—ulcerative colitis	8.71e-05	0.000744	CcSEcCtD
Rivaroxaban—Pruritus—Methylprednisolone—ulcerative colitis	8.69e-05	0.000742	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism—CHP1—ulcerative colitis	8.66e-05	0.00473	CbGpPWpGaD
Rivaroxaban—Dizziness—Hydrocortisone—ulcerative colitis	8.64e-05	0.000738	CcSEcCtD
Rivaroxaban—ABCB1—Allograft Rejection—IL17A—ulcerative colitis	8.56e-05	0.00468	CbGpPWpGaD
Rivaroxaban—Dyspepsia—Prednisone—ulcerative colitis	8.56e-05	0.000731	CcSEcCtD
Rivaroxaban—Rash—Prednisolone—ulcerative colitis	8.44e-05	0.000721	CcSEcCtD
Rivaroxaban—Dermatitis—Prednisolone—ulcerative colitis	8.43e-05	0.00072	CcSEcCtD
Rivaroxaban—Diarrhoea—Methylprednisolone—ulcerative colitis	8.4e-05	0.000718	CcSEcCtD
Rivaroxaban—Fatigue—Prednisone—ulcerative colitis	8.38e-05	0.000716	CcSEcCtD
Rivaroxaban—Headache—Prednisolone—ulcerative colitis	8.38e-05	0.000716	CcSEcCtD
Rivaroxaban—Constipation—Prednisone—ulcerative colitis	8.32e-05	0.00071	CcSEcCtD
Rivaroxaban—Vomiting—Hydrocortisone—ulcerative colitis	8.31e-05	0.00071	CcSEcCtD
Rivaroxaban—Rash—Hydrocortisone—ulcerative colitis	8.24e-05	0.000704	CcSEcCtD
Rivaroxaban—Dermatitis—Hydrocortisone—ulcerative colitis	8.23e-05	0.000703	CcSEcCtD
Rivaroxaban—Headache—Hydrocortisone—ulcerative colitis	8.19e-05	0.000699	CcSEcCtD
Rivaroxaban—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	8.19e-05	0.00447	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—CALM3—ulcerative colitis	8.15e-05	0.00445	CbGpPWpGaD
Rivaroxaban—Dizziness—Triamcinolone—ulcerative colitis	8.14e-05	0.000695	CcSEcCtD
Rivaroxaban—Dizziness—Methylprednisolone—ulcerative colitis	8.12e-05	0.000694	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	8.11e-05	0.00443	CbGpPWpGaD
Rivaroxaban—Feeling abnormal—Prednisone—ulcerative colitis	8.01e-05	0.000684	CcSEcCtD
Rivaroxaban—Asthenia—Betamethasone—ulcerative colitis	8.01e-05	0.000684	CcSEcCtD
Rivaroxaban—Asthenia—Dexamethasone—ulcerative colitis	8.01e-05	0.000684	CcSEcCtD
Rivaroxaban—ABCB1—Allograft Rejection—IL12B—ulcerative colitis	7.96e-05	0.00435	CbGpPWpGaD
Rivaroxaban—Gastrointestinal pain—Prednisone—ulcerative colitis	7.95e-05	0.000679	CcSEcCtD
Rivaroxaban—Nausea—Prednisolone—ulcerative colitis	7.95e-05	0.000679	CcSEcCtD
Rivaroxaban—Pruritus—Dexamethasone—ulcerative colitis	7.9e-05	0.000675	CcSEcCtD
Rivaroxaban—Pruritus—Betamethasone—ulcerative colitis	7.9e-05	0.000675	CcSEcCtD
Rivaroxaban—Vomiting—Triamcinolone—ulcerative colitis	7.83e-05	0.000668	CcSEcCtD
Rivaroxaban—Vomiting—Methylprednisolone—ulcerative colitis	7.81e-05	0.000667	CcSEcCtD
Rivaroxaban—Nausea—Hydrocortisone—ulcerative colitis	7.76e-05	0.000663	CcSEcCtD
Rivaroxaban—Rash—Triamcinolone—ulcerative colitis	7.76e-05	0.000663	CcSEcCtD
Rivaroxaban—Dermatitis—Triamcinolone—ulcerative colitis	7.75e-05	0.000662	CcSEcCtD
Rivaroxaban—Rash—Methylprednisolone—ulcerative colitis	7.74e-05	0.000661	CcSEcCtD
Rivaroxaban—Dermatitis—Methylprednisolone—ulcerative colitis	7.74e-05	0.000661	CcSEcCtD
Rivaroxaban—Urticaria—Prednisone—ulcerative colitis	7.73e-05	0.00066	CcSEcCtD
Rivaroxaban—Headache—Triamcinolone—ulcerative colitis	7.71e-05	0.000658	CcSEcCtD
Rivaroxaban—Headache—Methylprednisolone—ulcerative colitis	7.69e-05	0.000657	CcSEcCtD
Rivaroxaban—Abdominal pain—Prednisone—ulcerative colitis	7.69e-05	0.000657	CcSEcCtD
Rivaroxaban—Diarrhoea—Dexamethasone—ulcerative colitis	7.64e-05	0.000653	CcSEcCtD
Rivaroxaban—Diarrhoea—Betamethasone—ulcerative colitis	7.64e-05	0.000653	CcSEcCtD
Rivaroxaban—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	7.61e-05	0.00416	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—CTLA4—ulcerative colitis	7.48e-05	0.00409	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—DLD—ulcerative colitis	7.47e-05	0.00408	CbGpPWpGaD
Rivaroxaban—Dizziness—Betamethasone—ulcerative colitis	7.38e-05	0.000631	CcSEcCtD
Rivaroxaban—Dizziness—Dexamethasone—ulcerative colitis	7.38e-05	0.000631	CcSEcCtD
Rivaroxaban—Nausea—Triamcinolone—ulcerative colitis	7.31e-05	0.000624	CcSEcCtD
Rivaroxaban—Nausea—Methylprednisolone—ulcerative colitis	7.29e-05	0.000623	CcSEcCtD
Rivaroxaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	7.25e-05	0.00396	CbGpPWpGaD
Rivaroxaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	7.24e-05	0.00395	CbGpPWpGaD
Rivaroxaban—Hypersensitivity—Prednisone—ulcerative colitis	7.16e-05	0.000612	CcSEcCtD
Rivaroxaban—Vomiting—Dexamethasone—ulcerative colitis	7.1e-05	0.000606	CcSEcCtD
Rivaroxaban—Vomiting—Betamethasone—ulcerative colitis	7.1e-05	0.000606	CcSEcCtD
Rivaroxaban—Rash—Betamethasone—ulcerative colitis	7.04e-05	0.000601	CcSEcCtD
Rivaroxaban—Rash—Dexamethasone—ulcerative colitis	7.04e-05	0.000601	CcSEcCtD
Rivaroxaban—Dermatitis—Dexamethasone—ulcerative colitis	7.03e-05	0.000601	CcSEcCtD
Rivaroxaban—Dermatitis—Betamethasone—ulcerative colitis	7.03e-05	0.000601	CcSEcCtD
Rivaroxaban—Headache—Dexamethasone—ulcerative colitis	7e-05	0.000597	CcSEcCtD
Rivaroxaban—Headache—Betamethasone—ulcerative colitis	7e-05	0.000597	CcSEcCtD
Rivaroxaban—Asthenia—Prednisone—ulcerative colitis	6.98e-05	0.000596	CcSEcCtD
Rivaroxaban—Pruritus—Prednisone—ulcerative colitis	6.88e-05	0.000588	CcSEcCtD
Rivaroxaban—Diarrhoea—Prednisone—ulcerative colitis	6.65e-05	0.000568	CcSEcCtD
Rivaroxaban—Nausea—Dexamethasone—ulcerative colitis	6.63e-05	0.000567	CcSEcCtD
Rivaroxaban—Nausea—Betamethasone—ulcerative colitis	6.63e-05	0.000567	CcSEcCtD
Rivaroxaban—F10—Metabolism of proteins—GHRL—ulcerative colitis	6.62e-05	0.00362	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—HLA-DQA1—ulcerative colitis	6.59e-05	0.0036	CbGpPWpGaD
Rivaroxaban—Dizziness—Prednisone—ulcerative colitis	6.43e-05	0.000549	CcSEcCtD
Rivaroxaban—Vomiting—Prednisone—ulcerative colitis	6.18e-05	0.000528	CcSEcCtD
Rivaroxaban—Rash—Prednisone—ulcerative colitis	6.13e-05	0.000524	CcSEcCtD
Rivaroxaban—Dermatitis—Prednisone—ulcerative colitis	6.13e-05	0.000523	CcSEcCtD
Rivaroxaban—Headache—Prednisone—ulcerative colitis	6.09e-05	0.00052	CcSEcCtD
Rivaroxaban—CYP3A5—Biological oxidations—PTGS1—ulcerative colitis	6.09e-05	0.00333	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—IL10—ulcerative colitis	5.82e-05	0.00318	CbGpPWpGaD
Rivaroxaban—Nausea—Prednisone—ulcerative colitis	5.78e-05	0.000493	CcSEcCtD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	5.56e-05	0.00304	CbGpPWpGaD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	5.33e-05	0.00291	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—MMP1—ulcerative colitis	5.23e-05	0.00286	CbGpPWpGaD
Rivaroxaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	5.04e-05	0.00276	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	4.74e-05	0.00259	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—HLA-DRB1—ulcerative colitis	4.69e-05	0.00256	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—MMP1—ulcerative colitis	4.12e-05	0.00225	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—ALB—ulcerative colitis	3.97e-05	0.00217	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	3.95e-05	0.00216	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—JAK2—ulcerative colitis	3.69e-05	0.00201	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PTGS1—ulcerative colitis	3.61e-05	0.00197	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	3.55e-05	0.00194	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—IFNG—ulcerative colitis	3.42e-05	0.00187	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	3.28e-05	0.00179	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	3.28e-05	0.00179	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CALM3—ulcerative colitis	3.25e-05	0.00178	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—IL2—ulcerative colitis	3.22e-05	0.00176	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—CXCL8—ulcerative colitis	3.18e-05	0.00174	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	3.11e-05	0.0017	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—IL1B—ulcerative colitis	3.05e-05	0.00167	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—IL2—ulcerative colitis	3.04e-05	0.00166	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	2.83e-05	0.00155	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—CXCL8—ulcerative colitis	2.65e-05	0.00145	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ABCB1—ulcerative colitis	2.53e-05	0.00138	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—TGFB1—ulcerative colitis	2.51e-05	0.00137	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CHP1—ulcerative colitis	2.5e-05	0.00136	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	2.37e-05	0.0013	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ADCY5—ulcerative colitis	2.36e-05	0.00129	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—TNF—ulcerative colitis	2.22e-05	0.00121	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—DLD—ulcerative colitis	2.15e-05	0.00118	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—TP53—ulcerative colitis	2.06e-05	0.00113	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	2.04e-05	0.00111	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CHP1—ulcerative colitis	1.88e-05	0.00103	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PPARG—ulcerative colitis	1.76e-05	0.000961	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—DLD—ulcerative colitis	1.63e-05	0.000888	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	1.62e-05	0.000884	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ALB—ulcerative colitis	1.58e-05	0.000864	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.41e-05	0.000768	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PTGS2—ulcerative colitis	1.38e-05	0.000756	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.17e-05	0.000639	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CHP1—ulcerative colitis	1.16e-05	0.000634	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.1e-05	0.000599	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.09e-05	0.000597	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PTGS1—ulcerative colitis	1.04e-05	0.000569	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—DLD—ulcerative colitis	1e-05	0.000547	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	9.64e-06	0.000526	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CALM3—ulcerative colitis	9.38e-06	0.000512	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PTGS1—ulcerative colitis	7.86e-06	0.000429	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	7.35e-06	0.000401	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ABCB1—ulcerative colitis	7.29e-06	0.000398	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CALM3—ulcerative colitis	7.07e-06	0.000386	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ADCY5—ulcerative colitis	6.8e-06	0.000371	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ADCY5—ulcerative colitis	5.13e-06	0.00028	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PPARG—ulcerative colitis	5.07e-06	0.000277	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PTGS1—ulcerative colitis	4.84e-06	0.000264	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALB—ulcerative colitis	4.56e-06	0.000249	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CALM3—ulcerative colitis	4.36e-06	0.000238	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PTGS2—ulcerative colitis	3.99e-06	0.000218	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPARG—ulcerative colitis	3.83e-06	0.000209	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALB—ulcerative colitis	3.44e-06	0.000188	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ABCB1—ulcerative colitis	3.39e-06	0.000185	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ADCY5—ulcerative colitis	3.16e-06	0.000173	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PTGS2—ulcerative colitis	3.01e-06	0.000164	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPARG—ulcerative colitis	2.36e-06	0.000129	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALB—ulcerative colitis	2.12e-06	0.000116	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PTGS2—ulcerative colitis	1.86e-06	0.000101	CbGpPWpGaD
